Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines
from Info Risk Today Podcast Hosted by InfoRiskToday.com
While recent draft guidance from the Food and Drug Administration on artificial intelligence-enabled medical devices is non-binding, the document signals that the agency is intensifying its regulatory scrutiny of these technologies, said Dr. Scott Schell of IT consulting firm Cognizant.
Embed this episode
No transcript yet.
Frequently asked questions
When was this Info Risk Today Podcast episode published?
This episode was published on March 26, 2025.
Can I download this Info Risk Today Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.